These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 2167340)
1. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340 [TBL] [Abstract][Full Text] [Related]
2. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients]. Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058 [TBL] [Abstract][Full Text] [Related]
3. Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient. Bevilacqua F; Marcello A; Toni M; Zavattoni M; Cusini M; Zerboni R; Gerna G; Palù G J Acquir Immune Defic Syndr (1988); 1991; 4(10):967-9. PubMed ID: 1832460 [TBL] [Abstract][Full Text] [Related]
4. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections. Birch CJ; Tyssen DP; Tachedjian G; Doherty R; Hayes K; Mijch A; Lucas CR J Infect Dis; 1992 Jul; 166(1):108-12. PubMed ID: 1318909 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome. Sall RK; Kauffman CL; Levy CS Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. Chatis PA; Miller CH; Schrager LE; Crumpacker CS N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137 [No Abstract] [Full Text] [Related]
7. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. Marks GL; Nolan PE; Erlich KS; Ellis MN Rev Infect Dis; 1989; 11(3):474-6. PubMed ID: 2546244 [TBL] [Abstract][Full Text] [Related]
8. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS. MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706 [TBL] [Abstract][Full Text] [Related]
9. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436 [TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet. Stellbrink HJ; Albrecht H; Löning T; Greten H Klin Wochenschr; 1991 Apr; 69(6):274-8. PubMed ID: 1828096 [TBL] [Abstract][Full Text] [Related]
13. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial. Hardy WD Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285 [TBL] [Abstract][Full Text] [Related]
14. Foscarnet effective in acyclovir-resistant herpes. Am Pharm; 1991 Nov; NS31(11):12. PubMed ID: 1836936 [No Abstract] [Full Text] [Related]
15. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds. Harmenberg J; Wahren B; Sundqvist VA; Levén B J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239 [TBL] [Abstract][Full Text] [Related]
16. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial. Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751 [TBL] [Abstract][Full Text] [Related]
17. Characterization of acyclovir-resistant and -sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency. Schinazi RF; del Bene V; Scott RT; Dudley-Thorpe JB J Antimicrob Chemother; 1986 Oct; 18 Suppl B():127-34. PubMed ID: 3025153 [TBL] [Abstract][Full Text] [Related]
18. [Development of resistance of herpes simplex virus to antivirus drugs in vitro]. Chen ZJ; Liu WG; Song JZ Yao Xue Xue Bao; 1992; 27(1):10-4. PubMed ID: 1382356 [TBL] [Abstract][Full Text] [Related]